{"id":"W2030908978","doi":"10.2174/187152011796011109","title":"Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma","year":2011,"lang":"en","type":"review","venue":"Anti-Cancer Agents in Medicinal Chemistry","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Glypican 3; Hepatocellular carcinoma; Cancer research; Monoclonal antibody; Immunohistochemistry; Oncofetal antigen; Medicine; Pathology; Antibody; Biology; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005184371,0.0007569555,0.003076911,0.0002975421,0.00003826772,0.000009111753,0.0004304008,0.0007129324,0.001661327],"category_scores_gemma":[0.00005070111,0.000625424,0.0006977286,0.0007121796,0.0002286183,0.00005480942,0.0001232147,0.001074695,0.00001858021],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004197777,"about_ca_system_score_gemma":0.0007940046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007059223,"about_ca_topic_score_gemma":0.000003938683,"domain_scores_codex":[0.9962059,0.0001519356,0.00152046,0.0008403608,0.000574505,0.0007068691],"domain_scores_gemma":[0.9984002,0.00005857164,0.0006072265,0.0006061643,0.00009082258,0.000237081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001285741,0.0006610912,0.6583686,0.0550507,0.0005699454,0.002682302,0.0002867942,2.779723e-7,0.0006949514,0.000003225379,0.0001950836,0.2813585],"study_design_scores_gemma":[0.01580821,0.0008333328,0.02083836,0.1420757,0.01718923,0.0007900383,0.000758054,0.001546965,0.02970467,0.00007085952,0.7665048,0.003879774],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1818662,0.8159893,0.000005924536,0.00002001966,0.0001929051,0.0009315838,0.00003532746,0.00002268715,0.0009360372],"genre_scores_gemma":[0.3984521,0.6005074,0.00004411088,0.00003495764,0.0002551787,0.000175394,0.0002213015,0.00007148554,0.0002380977],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7663097,"threshold_uncertainty_score":0.9996197,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1284621606049395,"score_gpt":0.3375057856867938,"score_spread":0.2090436250818543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}